Pfizer and Merck COVID-19 Drugs to Hit Commercial Market Nov. 1: Report
Joe Raedle COVID-19 treatments manufactured by Pfizer (New York Stock Exchange:PFE) and Merck (New York Stock Exchange: MRK) will supposedly ...
Tag: Pfizer
Morningstar’s optimism about biotech; Pfizer is among the options
Biotech stocks have suffered this year amid concerns about government moves to cap drug prices and scrutinize acquisitions. Investors are ...
Pfizer closes $43 billion acquisition deal with cancer drug maker Seagen
Pfizer has been on an acquisition spree as it seeks to cushion the impact of a projected $17 billion drop ...
Pfizer, AbbVie, GSK, Eli Lilly among drugmakers to raise prices (NYSE:PFE)
Sorry Pharmaceutical companies started 2023 strong, raising prices for about 450 drugs this month, with more price hikes expected, according ...
Recommended.
